We are live on ! Find out more

8 hedge funds and large institutions have $1.39M invested in Daxor in 2025 Q2 according to their latest regulatory filings, with funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,185% more capital inflows, than outflows

Capital inflows: $79K | Capital outflows: $3.46K

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

0.19% more ownership

Funds ownership: 2.75% → 2.94% (+0.19%)

11% less funds holding

Funds holding: 9 → 8 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
8
Holders Change
-1
Holders Change %
-11.11%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
3
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

DXR Hedge Fund Activity: Q2 2025 in Review

8 of the 7,630 institutional investors tracked by Wall St. Rank reported a position in Daxor (DXR) for Q2 2025, worth a combined $1.39M — up 29% from $1.08M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of DXR and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 3 added.

The largest buyer was BFC Planning, Inc., adding an estimated $45.2K. The largest seller was UBS Group, exiting entirely with an estimated $2.65K sold.

  • 8 institutional investors held Daxor (DXR) as of Q2 2025, down from 9 in Q1 2025.
  • Funds reported $1.39M of Daxor stock for Q2 2025, up 29% quarter-over-quarter.
  • 0 funds opened new Daxor positions in Q2 2025 and 1 closed out, a net change of -1 holder.
  • The largest Daxor buyer in Q2 2025 was BFC Planning, Inc., an estimated $45.2K added.
  • The largest Daxor seller in Q2 2025 was UBS Group, an estimated $2.65K sold.

Based on aggregated 13F filings for Q2 2025.